# Contineum Therapeutics, Inc.: Form 8-K, filed May 20, 2024

- Company: [Contineum Therapeutics, Inc.](/companies/ctnm.md) (CIK 1855175)
- Form: 8-K
- Filed: 2024-05-20
- Accepted by EDGAR: May 20, 2024, 16:09 ET
- Period: 2024-05-20
- Accession: 0001437749-24-017651
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1855175/000143774924017651/cont20240420_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1855175/000143774924017651/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1855175/000143774924017651/cont20240420_8k.htm

Filed May 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-017651. Last ingested by Listed: Nov 6, 2026, 12:53 ET. No prices; not investment advice.